30 unchanged sentences
We also have audited, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), the consolidated balance sheets of Inspire Medical Systems, Inc.
−Removed: as of December 31, 2023 and 2022, the related consolidated statements of operations and comprehensive loss, stockholders' equity and cash flows for each of the three years in the period ended December 31, 2023, and the related notes and our report dated February 9, 2024 expressed an unqualified opinion thereon.
+Added: as of December 31, 2024 and 2023, the related consolidated statements of operations and comprehensive income (loss), stockholders' equity and cash flows for each of the three years in the period ended December 31, 2024, and the related notes and our report dated February 10, 2025 expressed an unqualified opinion thereon.
Basis for Opinion
21 unchanged sentences
Adoption/Termination Date Aggregate Number of Shares of Common Stock to be Sold Expiration Date
−Removed: Rondoni Chief Technology Officer Terminate November 23, 2023 12,992 June 28, 2024
−Removed: Rondoni Chief Technology Officer Adopt November 30, 2023 12,992 November 29, 2024
−Removed: Jerry Griffin, M.D.
−Removed: Director Terminate November 30, 2023 17,296 November 30, 2023
−Removed: Jerry Griffin, M.D.
−Removed: Director Adopt November 30, 2023 4,296 May 30, 2024
−Removed: There were no other Rule 10b5-1 trading arrangements or non-Rule 10b5-1 trading arrangements adopted , modified or terminated by the Company’s directors and executive officers during the quarter ended December 31, 2023.
+Added: Shawn T McCormick Director Terminate November 1, 2024 1,050 May 2, 2025
+Added: Shawn T McCormick Director Adopt November 13, 2024 8,600 August 15, 2025
+Added: Buchholz Chief Financial Officer Adopt November 13, 2024 15,000 November 28, 2025
+Added: Randall Ban EVP Patient Access and Therapy Development Adopt November 13, 2024 25,000 August 15, 2025
+Added: Bryan Phillips General Counsel Adopt November 27, 2024 6,152 (1)
+Added: September 30, 2025
+Added: (1) This number includes shares of our common stock issuable pursuant to performance stock units (“PSU”) that may vest during the term of the 10b5-1 plan, subject to the achievement of certain performance conditions as set forth in the applicable PSU agreement.
+Added: The actual number of PSUs that vest following the end of the applicable performance period, if any, and therefore the resulting shares of our common stock available for sale under the plan will depend on the attainment of the performance metrics.
+Added: Also, shares of our common stock issuable pursuant to vested PSUs will be subject to tax withholding obligations that may reduce the net shares actually issued and, therefore, available for sale under the applicable plan;
+Added: however, the maximum aggregate gross number of shares of our common stock included in the applicable plan is reported in this table without reduction for such future tax obligations and assuming maximum achievement of the performance conditions under the PSUs.
+Added: There were no other "Rule 10b5-1 trading arrangements" or "non-Rule 10b5-1 trading arrangements," as each term is defined in Item 408(a) of Regulation S-K, adopted , modified or terminated by the Company’s directors or "officers" (as defined in Rule 16a-1(f) of the Exchange Act) during the quarter ended December 31, 2024.
Disclosure Regarding Foreign Jurisdictions that Prevent Inspections.
99 unchanged sentences
S-1 333-224176 10.19 4/23/2018
−Removed: 10.17† Amended and Restated Employment Agreement, by and between Inspire Medical Systems, Inc.
−Removed: and Steven Jandrich
−Removed: S-1 333-224176 10.21 4/23/2018
−Removed: 10.18† Employment Agreement between the Company and Philip Ebeling
−Removed: 8-K 001-38468 10.1 6/8/2020
10.17† Employment Agreement between the Company and Bryan Phillips
2 unchanged sentences
10-Q 001-38468 10.2 8/1/2023
−Removed: 10.21† Employment Agreement between the Company and Charisse Sparks
−Removed: 10-Q 001-38468 10.1 11/7/2023
+Added: 10.19† Employment Agreement between the Company and Jason Kelly
10.20† Form of Indemnification Agreement between Inspire Medical Systems, Inc.
4 unchanged sentences
10-Q 001-38468 10.1 5/7/2024
+Added: 19.1 Inspire Medical Systems, Inc.
+Added: Insider Trading Policy
21.1 Subsidiaries of Inspire Medical Systems, Inc.
8 unchanged sentences
Recovery of Erroneously Awarded Compensation Policy
−Removed: Number Description Form File No.
−Removed: Exhibit Filing
+Added: 97.1 2/9/2024 *
101.INS Inline XBRL Instance Document - the instance document does not appear in the Interactive Data File because its XBRL tags are embedded within the Inline XBRL document.
101.SCH Inline XBRL Taxonomy Extension Schema Document *
+Added: Number Description Form File No.
+Added: Exhibit Filing
101.CAL Inline XBRL Taxonomy Extension Calculation Linkbase Document *
21 unchanged sentences
/s/ TIMOTHY P.
−Removed: HERBERT Chief Executive Officer (principal executive officer), President and Director
+Added: HERBERT Chief Executive Officer (principal executive officer), President and Chair of the Board of Directors
/s/ RICHARD BUCHHOLZ Chief Financial Officer (principal financial and accounting officer)
Richard Buchholz
−Removed: /s/ MARILYN CARLSON NELSON Chair of the Board of Directors
−Removed: Marilyn Carlson Nelson
+Added: ELLIS Lead Independent Director
/s/ SHELLEY G.
3 unchanged sentences
/s/ MYRIAM J.
−Removed: ELLIS Director
−Removed: GRIFFIN, M.D.
−Removed: Griffin, M.D.
/s/ SHAWN T MCCORMICK Director
4 unchanged sentences
Compared sentence by sentence after normalising whitespace, quotation marks, case and digits, so re-formatting and restated figures do not read as changed language. Wording changes appear as one removal and one addition. The current filing and the prior one are authoritative.